Half-Life 2 is getting a major update in celebration of the classic title’s 20th anniversary. In addition to Steam Workshop ...

Halozyme Therapeutics said on Thursday it has proposed to buy German drug developer Evotec for about 2 billion euros ($2.10 billion), to bulk up its drug discovery and development portfolio.

BECOME A MEMBER: <a href=" SUBSCRIBE OR I TAKE YOUR NERF GUN ╔═╦╗╔╦╗╔═╦═╦╦╦╦╗╔═╗ ║╚╣║║║╚╣╚╣╔╣╔╣║╚╣═╣ ╠╗║╚╝║║╠╗║╚╣║║║║║═╣ ...

Van ECK Associates Corp reduced its position in Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 35.5% in the 3rd quarter, according to the company in its most recent 13F filing with the ...

Something very special happened in our hobby this weekend. The Digsite team, a group of Halo modders who've been working with ...

A "new" Halo 2 demo release has hit the Steam community pages. A Nostalgic romp through a special demo and more, click here ...

Celebrating 20 years of Halo 2. In 2001, the world of console gaming and first-person shooters was forever changed by the release of Microsoft’s Xbox platform with a launch title named Halo: Combat ...

Halo 2's iconic E3 demo will be available as a free mod for the Halo: The Master Chief Collection on Steam starting on ...

Halozyme's Q3 earnings exceeded expectations, with a $1.27 EPS and 34% YoY revenue growth, driven by ENHANZE tech and strong ...

Publisher Xbox Game Studios and developer Halo Studios will release the Halo 2 demo showcased at E3 2003, which never made it into the final version of the game, for the PC (Steam) version of ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

On Thursday, Halozyme Therapeutics, Inc. (HALO) stock saw a decline, ending the day at $50.57 which represents a decrease of $-0.02 or -0.04% from the prior close of $50.59. The stock opened at $50.56 ...